Drug Type Dual payload Antibody drug conjugate (Dual payload ADC) |
Synonyms KH815 |
Target |
Action inhibitors |
Mechanism POLR2A inhibitors(DNA-directed RNA polymerase II subunit RPB1 inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors), Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | - | 30 Apr 2025 | |
Neoplasms | Preclinical | China | 28 Apr 2025 |